Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID	Title	Status	Phase
NCT01493843	Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer	COMPLETED	PHASE2
NCT00347412	Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer	COMPLETED	PHASE3
NCT00373425	A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors	COMPLETED	PHASE3
NCT03215706	A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC	COMPLETED	PHASE3
NCT03447769	Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A	TERMINATED	PHASE3
NCT00409188	Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)	COMPLETED	PHASE3
NCT03782207	A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice	ACTIVE_NOT_RECRUITING	—
NCT00049998	Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer	COMPLETED	PHASE3
NCT00981058	First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin	COMPLETED	PHASE3
NCT02043665	CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)	COMPLETED	PHASE1

Related Pages

All Non-small cell lung cancer trials All trials in Guildford, United Kingdom